Awards & Advancement

Chapple joins Quanticate

Friday, November 18, 2011 10:30 AM

Quanticate has named Dr. Daniel Chapple vice pesident of business development and marketing, effective immediately.  He will report to Quanticate's chairman and chief executive officer David Underwood and will be based out of Quanticate’s offices in the UK and Boston, MA. In his new role, Chapple will be responsible for working with the leadership team to further develop the Centralized Clinical Data Sciences solution which is focused on the importance of data to successfully gain approval and market new products through the use of technology coupled with highly skilled statisticians, programmers, data managers, medical writers and pharmacovigilance experts.

More... »

Agios raises $78 million in financing

Thursday, November 17, 2011 11:18 AM

Agios Pharmaceuticals has secured $78 million in an oversubscribed Series C financing. The proceeds of this financing will be used to advance the company's rapidly emerging portfolio of cancer metabolism therapeutics into the clinic and to expand research and development into inborn errors of metabolism (IEMs), a group of genetic disorders with high unmet medical need.

More... »

Allena Pharmaceuticals secures $15 million in Series A financing

Wednesday, November 16, 2011 03:03 PM

Allena Pharmaceuticals, a company developing and commercializing innovative non-systemic oral protein therapeutics, has secured $15 million in Series A venture capital financing. Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures led the round. Proceeds from the financing will be used to accelerate the development of Allena's non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.

More... »

Theorem names VP, EMEA

Wednesday, November 16, 2011 02:19 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Christian Tucat vice president & general manager, Europe Middle East & Africa. In this role, Tucat will have direct accountability for sales and the P&L of Theorem’s business in these regions.

More... »

Accelovance names chief medical officer

Monday, November 14, 2011 02:33 PM

Accelovance has named Stephan A. Bart Sr., M.D. chief medical officer. Bart will be responsible for medical affairs and site operations, focused on enhancing the level of clinical solutions Accelovance can provide to clients.

More... »

Avaxia raises $2.2 million in Series A financing

Friday, November 11, 2011 10:44 AM

Avaxia Biologics, a privately-held biotech company, has completed its first close of $2.2 million of a Series A angel-led financing. Cherrystone Angels of Providence, Rhode Island led the round, with participation from Boston Harbor Angels and other undisclosed individuals. Mr. Robert Manning, the co-Chairman of Cherrystone Angels, will join the Avaxia board.

More... »

Merge Healthcare names senior executives

Thursday, November 10, 2011 09:52 AM

More... »

Rempex raises $67.5 million in Series B financing

Wednesday, November 9, 2011 02:06 PM

Rempex Pharmaceuticals has completed the initial closing of a Series B financing.  New investors Frazier Healthcare Ventures and Vivo Ventures joined existing investors SV Life Sciences, OrbiMed Advisors and Adams Street Partners in committing to a total of $67.5 million for this round.  This financing, together with a previous Series A round, brings the total financing commitment for Rempex to $76 million since the company's founding in June 2011.

More... »

Rhythm names CEO

Wednesday, November 9, 2011 08:34 AM

Rhythm, a biotechnology company, has named Keith M. Gottesdiener, MD, chief executive officer.

More... »

Hoffman joins Theorem Clinical Research

Tuesday, November 8, 2011 03:35 PM

Theorem Clinical Research, previously Omnicare Clinical Research, has named Marc Hoffman, MD, senior vice president and general manager for their newly formed pharmaceutical development business unit. In his new role, Hoffman will have strategic oversight for Theorem’s core CRO operation, including project management, clinical monitoring, SMART (site management and patient recruitmenT), and pharmaceutics. He will also oversee the company’s medical operations. 

More... »